64Cu-DOTA-Anti-CTLA-4 mAb Enabled PET Visualization of CTLA-4 on the T-Cell Infiltrating Tumor Tissues
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
64Cu-DOTA-Anti-CTLA-4 mAb Enabled PET Visualization of CTLA-4 on the T-Cell Infiltrating Tumor Tissues
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 11, Pages e109866
Publisher
Public Library of Science (PLoS)
Online
2014-11-04
DOI
10.1371/journal.pone.0109866
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas
- (2013) Sibaprasad Bhattacharyya et al. NUCLEAR MEDICINE AND BIOLOGY
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
- (2013) M. J. Selby et al. Cancer Immunology Research
- Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
- (2012) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Advances in Immuno–Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology
- (2012) Scott M. Knowles et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypophysitis Induced by Monoclonal Antibodies to Cytotoxic T Lymphocyte Antigen 4: Challenges from a New Cause of a Rare Disease
- (2012) F. Torino et al. ONCOLOGIST
- Exploration of target molecules for molecular imaging of inflammatory bowel disease
- (2011) Kei Higashikawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Soluble CTLA-4 Splice Variant Protects From Type 1 Diabetes and Potentiates Regulatory T-Cell Function
- (2011) K. D. Gerold et al. DIABETES
- The mechanisms of cancer immunoescape and development of overcoming strategies
- (2011) Tomonori Yaguchi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Overexpression of the CTLA-4 Isoform Lacking Exons 2 and 3 Causes Autoimmunity
- (2011) S. M. Liu et al. JOURNAL OF IMMUNOLOGY
- Ipilimumab
- (2011) Vernon K. Sondak et al. NATURE REVIEWS DRUG DISCOVERY
- Cancer immunotherapy – revisited
- (2011) W. Joost Lesterhuis et al. NATURE REVIEWS DRUG DISCOVERY
- Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts
- (2010) Bishnuhari Paudyal et al. CANCER SCIENCE
- Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
- (2010) J. Mitsui et al. CLINICAL CANCER RESEARCH
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- 89Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922
- (2010) W. B. Nagengast et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular mechanism and function of CD40/CD40L engagement in the immune system
- (2009) Raul Elgueta et al. IMMUNOLOGICAL REVIEWS
- Genetic Evidence That the Differential Expression of the Ligand-Independent Isoform of CTLA-4 Is the Molecular Basis of the Idd5.1 Type 1 Diabetes Region in Nonobese Diabetic Mice
- (2009) M. Araki et al. JOURNAL OF IMMUNOLOGY
- PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models
- (2009) G. Niu et al. JOURNAL OF NUCLEAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search